Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,489 | -1,561 | -8,424 | -6,212 | -4,073 |
| Depreciation Amortization | 351 | 175 | 696 | 522 | 347 |
| Accounts payable and accrued liabilities | 526 | 238 | 803 | 646 | 694 |
| Other Working Capital | 530 | 283 | 568 | 350 | 654 |
| Other Operating Activity | -479 | -569 | -445 | -436 | -743 |
| Operating Cash Flow | $-2,560 | $-1,434 | $-6,803 | $-5,131 | $-3,121 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -4 | -74 | -64 | -58 |
| Investing Cash Flow | $-4 | $-4 | $-74 | $-64 | $-58 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,100 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 2,350 | 2,350 | N/A |
| Other Financing Activity | -383 | -242 | 0 | 0 | 0 |
| Financing Cash Flow | $717 | $-242 | $2,350 | $2,350 | $N/A |
| Beginning Cash Position | 2,555 | 2,555 | 7,082 | 7,082 | 7,082 |
| End Cash Position | 708 | 875 | 2,555 | 4,237 | 3,904 |
| Net Cash Flow | $-1,848 | $-1,680 | $-4,527 | $-2,845 | $-3,178 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,560 | -1,434 | -6,803 | -5,131 | -3,121 |
| Capital Expenditure | -4 | -4 | -74 | -64 | -58 |
| Free Cash Flow | -2,564 | -1,438 | -6,877 | -5,195 | -3,178 |